Therapy against IL-5 hampers eosinophil maturation, activation, and survival, whereas the corticosteroid therapy causes eosinophil apoptosis, favoring the switch to a more neutrophilic phenotype of asthma when administered at the highest dose [34]. The gene discussed is IL5; the disease is asthma.